Lipid Metabolism Practice Questions

Q: Where does beta-oxidation of fatty acids occur?

Mitochondria. **Explanation:** **Beta-oxidation of fatty acids** is the primary metabolic pathway for the breakdown of long-chain fatty acids to generate energy in the form of ATP. **Why Mitochondria is correct:** The majority of fatty acid oxidation occurs within the **mitochondrial matrix**. After fatty acids are activated in the cytosol to Fatty Acyl-CoA, they are transported across the inner mitochondrial membrane via the **Carnitine Shuttle** (the rate-limiting step). Once inside the matrix, the fatty acid undergoes a four-step cyclic process (oxidation, hydration, oxidation, and thiolysis), yielding Acetyl-CoA, NADH, and FADH₂. Acetyl-CoA then enters the TCA cycle for further energy production. **Why other options are incorrect:** * **Peroxisomes:** While very-long-chain fatty acids (VLCFA, >22 carbons) begin oxidation in peroxisomes, the process is incomplete and must be finished in the mitochondria. * **Cytosol:** This is the site for fatty acid **synthesis** (lipogenesis), not oxidation. The separation of these pathways (synthesis in cytosol vs. oxidation in mitochondria) prevents a futile cycle. * **Golgi apparatus:** This organelle is involved in the modification, sorting, and packaging of proteins and lipids, but not their catabolism. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Carnitine Palmitoyltransferase-I (CPT-I). * **Inhibitor:** Malonyl-CoA (an intermediate of fatty acid synthesis) inhibits CPT-I, preventing simultaneous synthesis and breakdown. * **Clinical Correlation:** **Zellweger Syndrome** is a peroxisomal biogenesis disorder leading to the accumulation of VLCFAs. **MCAD deficiency** is the most common inborn error of beta-oxidation, presenting with hypoketotic hypoglycemia.

Q: Fatty acid oxidation occurs in which cellular compartment?

Mitochondria. ### Explanation **Correct Answer: C. Mitochondria** **Underlying Medical Concept:** Fatty acid oxidation (specifically **Beta-oxidation**) is the primary process by which fatty acids are broken down to generate energy (ATP). This process occurs within the **mitochondrial matrix**. Long-chain fatty acids are transported from the cytosol into the mitochondria via the **Carnitine Shuttle** (the rate-limiting step). Once inside, the fatty acids undergo a repetitive four-step cycle (oxidation, hydration, oxidation, and thiolysis) to produce Acetyl-CoA, NADH, and FADH₂, which then enter the TCA cycle and Electron Transport Chain to yield energy. **Analysis of Incorrect Options:** * **A. Cytoplasm:** While fatty acid **synthesis** (Lipogenesis) occurs in the cytoplasm, oxidation does not. The cytoplasm is the site for the activation of fatty acids into Fatty Acyl-CoA, but the actual breakdown happens inside the mitochondria. * **B. Microsomes:** Microsomes (Endoplasmic Reticulum) are involved in the **elongation** of fatty acid chains and **omega-oxidation** (a minor pathway), but they are not the site for the primary beta-oxidation pathway. * **D. All of the above:** This is incorrect because the enzymes for the beta-oxidation spiral are localized specifically within the mitochondrial matrix. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Carnitine Palmitoyltransferase-I (CPT-I). * **Inhibitor:** Malonyl-CoA (an intermediate of synthesis) inhibits CPT-I, preventing a futile cycle where synthesis and oxidation happen simultaneously. * **Alternative Sites:** **Very Long Chain Fatty Acids (VLCFA)** undergo initial oxidation in **Peroxisomes** (Zellweger Syndrome is a clinical correlation here). * **Energy Yield:** The complete oxidation of one molecule of **Palmitate (16C)** yields a net of **106 ATP**.

Q: Which lipoprotein carries the highest amount of cholesterol?

Low-density lipoprotein (LDL). **Explanation:** The correct answer is **Low-density lipoprotein (LDL)**. Lipoproteins are classified based on their density and composition of lipids (triacylglycerols, cholesterol, phospholipids) and proteins. **Why LDL is the correct answer:** LDL is the primary carrier of cholesterol in the blood, transporting it from the liver to peripheral tissues. It is derived from VLDL via IDL. As VLDL loses triglycerides through the action of lipoprotein lipase, the relative proportion of cholesterol increases. LDL contains approximately **50% cholesterol** (mostly cholesterol esters), making it the most cholesterol-rich lipoprotein. **Analysis of Incorrect Options:** * **HDL (High-density lipoprotein):** Known as "good cholesterol," it has the highest **protein** content (approx. 50%) but contains less total cholesterol than LDL. Its role is reverse cholesterol transport (periphery to liver). * **VLDL (Very-low-density lipoprotein):** This lipoprotein is primarily composed of **endogenous triglycerides** (approx. 50-60%). It carries lipids from the liver to the periphery. * **IDL (Intermediate-density lipoprotein):** A transient intermediate between VLDL and LDL; it contains roughly equal amounts of triglycerides and cholesterol. **High-Yield Clinical Pearls for NEET-PG:** * **Chylomicrons:** Carry the highest amount of **triglycerides** (90%) and are the least dense. * **Apolipoprotein B-100:** The primary structural protein found in VLDL, IDL, and LDL. * **Friedewald Equation:** Used to calculate LDL cholesterol: $LDL = Total\ Cholesterol – (HDL + TG/5)$. (Note: Not applicable if TG >400 mg/dL). * **Oxidized LDL:** The key factor in atherogenesis and foam cell formation in arterial walls.

Q: Which of the following is true about Hypertriglyceridemia?

None of the above. **Explanation:** Hypertriglyceridemia refers to an elevated level of triglycerides in the blood, typically associated with abnormalities in **Chylomicrons** or **VLDL** (Very Low-Density Lipoproteins). **1. Why "None of the above" is correct:** The options provided describe conditions that either primarily involve cholesterol or represent a deficiency of lipids, rather than classic hypertriglyceridemia. True hypertriglyceridemia is seen in conditions like **Type I (Familial Chylomicronemia)**, **Type IV (Familial Hypertriglyceridemia)**, and **Type V Hyperlipoproteinemia**. **2. Analysis of Incorrect Options:** * **A. LDL receptor defect:** This is the hallmark of **Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia)**. It leads to isolated elevation of LDL and **cholesterol**, not triglycerides. * **B. Dysbetalipoproteinemia (Type III):** This is characterized by a defect in **Apo-E**, leading to the accumulation of IDL and Chylomicron remnants (Broad-beta disease). While it involves a rise in both cholesterol and triglycerides, it is specifically defined by "remnant" accumulation rather than pure hypertriglyceridemia. * **C. Abetalipoproteinemia:** This is a deficiency state caused by a mutation in the **MTP (Microsomal Triglyceride Transfer Protein)** gene. It results in a near-total absence of VLDL, LDL, and Chylomicrons, leading to *low* lipid levels, malabsorption, and acanthocytosis. **High-Yield Clinical Pearls for NEET-PG:** * **Pancreatitis Risk:** Severe hypertriglyceridemia (>1000 mg/dL) is a major risk factor for acute pancreatitis. * **Type I vs. Type IV:** Type I is due to **LPL (Lipoprotein Lipase)** or **Apo C-II** deficiency (creamy layer on top of plasma). Type IV is due to VLDL overproduction. * **Eruptive Xanthomas:** These are skin manifestations specifically associated with high triglyceride levels.

Q: Which of the following is not a polyunsaturated fatty acid (PUFA)?

Palmitoleic acid. ### Explanation The classification of fatty acids is based on the number of double bonds present in their hydrocarbon chain. **Polyunsaturated Fatty Acids (PUFAs)** are defined as fatty acids containing **two or more** double bonds. **Why Palmitoleic acid is the correct answer:** Palmitoleic acid is a **16-carbon** fatty acid with only **one** double bond located at the 9th carbon ($\omega$-7). Because it contains only a single double bond, it is classified as a **Monounsaturated Fatty Acid (MUFA)**, not a PUFA. **Analysis of Incorrect Options:** * **Linoleic acid (18:2, $\omega$-6):** Contains two double bonds. It is an essential PUFA and a precursor for arachidonic acid. * **Linolenic acid (18:3, $\omega$-3):** Contains three double bonds. It is an essential PUFA found in flaxseed and fish oils. * **Arachidonic acid (20:4, $\omega$-6):** Contains four double bonds. It is a semi-essential PUFA (essential if linoleic acid is deficient) and serves as the primary precursor for eicosanoids (prostaglandins, leukotrienes). **High-Yield NEET-PG Pearls:** 1. **Essential Fatty Acids:** Humans lack the enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) to introduce double bonds beyond the 9th carbon; hence, Linoleic and Linolenic acids must be obtained from the diet. 2. **Mnemonic for PUFAs:** "L-L-A" (Linoleic, Linolenic, Arachidonic). 3. **Oleic Acid (18:1, $\omega$-9):** The most common MUFA in the human diet (found in olive oil). 4. **Clinical Correlation:** Deficiency of essential PUFAs leads to **Phrynoderma** (toad skin), characterized by follicular hyperkeratosis.

Q: Which of the following enzymes is the most important enzyme for regulating lipogenesis?

Acetyl-CoA carboxylase. **Explanation:** **Acetyl-CoA Carboxylase (ACC)** is the correct answer because it catalyzes the **rate-limiting and committed step** in fatty acid synthesis (lipogenesis). This enzyme converts Acetyl-CoA to Malonyl-CoA using biotin as a cofactor, ATP, and CO₂. Its regulatory importance stems from two mechanisms: 1. **Allosteric Regulation:** It is activated by Citrate (signaling high energy) and inhibited by Palmitoyl-CoA (feedback inhibition). 2. **Hormonal Regulation:** It is activated by Insulin (via dephosphorylation) and inhibited by Glucagon/Epinephrine (via phosphorylation by AMPK). Furthermore, Malonyl-CoA produced by ACC inhibits *Carnitine Palmitoyltransferase-I (CPT-I)*, preventing a futile cycle by stopping fatty acid oxidation while synthesis is active. **Why other options are incorrect:** * **Hydratase, Enoyl reductase, and Acetyl transacetylase** are all components of the **Fatty Acid Synthase (FAS) multienzyme complex**. While essential for the elongation of the fatty acid chain, they are not regulatory or rate-limiting steps. They function downstream of ACC once the committed Malonyl-CoA is already formed. **High-Yield Clinical Pearls for NEET-PG:** * **Cofactors for ACC:** Remember **ABC** (ATP, Biotin, and CO₂). * **Location:** Lipogenesis occurs in the **cytosol**, whereas beta-oxidation occurs in the mitochondria. * **Citrate Shuttle:** Acetyl-CoA leaves the mitochondria in the form of Citrate to participate in lipogenesis. * **Metformin Link:** Metformin activates AMPK, which phosphorylates and inhibits ACC, contributing to its lipid-lowering effects.

Q: Which of the following best describes phospholipids?

Complex lipids. **Explanation:** Lipids are broadly classified based on their chemical composition. **Phospholipids** are categorized as **Complex (or Compound) lipids** because, upon hydrolysis, they yield not only fatty acids and an alcohol but also additional groups—specifically a phosphoric acid residue and often a nitrogenous base. **Why Option C is Correct:** Complex lipids are esters of fatty acids containing groups in addition to an alcohol and a fatty acid. Phospholipids are the most abundant complex lipids. They are further divided into: 1. **Glycerophospholipids:** Alcohol is glycerol (e.g., Lecithin, Cephalin). 2. **Sphingophospholipids:** Alcohol is sphingosine (e.g., Sphingomyelin). **Why Other Options are Incorrect:** * **Option A (Simple lipids):** These are esters of fatty acids with various alcohols but contain no other groups. Examples include **Triacylglycerols (TAGs)** and **Waxes**. * **Option B (Derived lipids):** These are substances derived from the hydrolysis of simple and complex lipids that still possess the characteristics of lipids. Examples include **steroids (cholesterol)**, fatty acids, and lipid-soluble vitamins. **NEET-PG High-Yield Pearls:** * **Lecithin (Phosphatidylcholine)** is the most abundant phospholipid in the cell membrane. * **Dipalmitoyl lecithin (DPPC)** acts as a lung surfactant; its deficiency leads to **Respiratory Distress Syndrome (RDS)** in neonates. * **Sphingomyelin** is the only phospholipid that does not contain glycerol; it is found in the myelin sheath. * **Cardiolipin** is a unique phospholipid found in the inner mitochondrial membrane and is antigenic in syphilis (used in the VDRL test).

Question 1

Where does beta-oxidation of fatty acids occur?

Accepted Answer

Mitochondria

Answer

Peroxisomes

Answer

Cytosol

Answer

Golgi apparatus

Question 2

Fatty acid oxidation occurs in which cellular compartment?

Accepted Answer

Mitochondria

Answer

Cytoplasm

Answer

Microsomes

Answer

All of the above

Question 3

Which lipoprotein carries the highest amount of cholesterol?

Accepted Answer

Low-density lipoprotein (LDL)

Answer

High-density lipoprotein (HDL)

Answer

Very-low-density lipoprotein (VLDL)

Answer

Intermediate-density lipoprotein (IDL)

Question 4

In chronic diabetics, why are the values of triglycerides (TG) and very-low-density lipoprotein (VLDL) elevated?

Accepted Answer

Increased activity of hormone-sensitive lipase and decreased lipoprotein lipase activity

Answer

Increased activity of hepatic lipase

Answer

Increased peripheral function of LDL receptors

Answer

Increased activity of lipoprotein lipase and decreased activity of hormone-sensitive lipase

Question 5

Which of the following is true about Hypertriglyceridemia?

Accepted Answer

None of the above

Answer

LDL receptor defect

Answer

Dysbetalipoprotenemia

Answer

Abetalipoprotenemia

Question 6

Which of the following is not a polyunsaturated fatty acid (PUFA)?

Accepted Answer

Palmitoleic acid

Answer

Linoleic acid

Answer

Linolenic acid

Answer

Arachidonic acid

Question 7

Which of the following enzymes is the most important enzyme for regulating lipogenesis?

Accepted Answer

Acetyl-CoA carboxylase

Answer

Hydratase

Answer

Enoyl reductase

Answer

Acetyl transacetylase

Question 8

Which of the following best describes phospholipids?

Accepted Answer

Complex lipids

Answer

Simple lipids

Answer

Derived lipids

Answer

None of the above

Question 9

A premature infant, when born, had low Apgar scores and was experiencing difficulty breathing. The NICU physician administered a lipid mixture that significantly reduced the respiratory distress. Besides proteins, what is a key component of this mixture?

Accepted Answer

Phosphatidylcholine

Answer

Sphingomyelin

Answer

A mixture of gangliosides

Answer

Triacylglycerol

Question 10

What is true about the lecithin-sphingomyelin ratio in amniotic fluid?

Accepted Answer

Concentration of lecithin and sphingomyelin in amniotic fluid are equal before 34 weeks.

Answer

Concentration of lecithin is greater than sphingomyelin in amniotic fluid before 34 weeks.

Answer

After 32 to 34 weeks, the concentration of sphingomyelin relative to lecithin begins to rise.

Answer

There is an increased risk of Respiratory Distress Syndrome if the L/S ratio is less than 2.

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?